SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-015493
Filing Date
2016-05-04
Accepted
2016-05-04 16:07:55
Documents
54
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q Q1 2016 ARBUTUS BIOPHARMA CORP arbutusq12016.htm 10-Q 900269
2 EXHIBIT 10.1 exhibit_pthterminationagre.htm EX-10.1 24700
3 EXHIBIT 31.1 Q1 2016 exhibit311q12016.htm EX-31.1 13499
4 EXHIBIT 31.2 Q1 2016 exhibit312q12016.htm EX-31.2 13981
5 EXHIBIT 32.1 Q1 2016 exhibit321q12016.htm EX-32.1 6606
6 EXHIBIT 32.2 Q1 2016 exhibit322q12016.htm EX-32.2 6947
13 imagehbvpipelie.jpg GRAPHIC 138134
  Complete submission text file 0001628280-16-015493.txt   4781633

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT abus-20160331.xml EX-101.INS 871637
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20160331.xsd EX-101.SCH 39876
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20160331_cal.xml EX-101.CAL 51381
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20160331_def.xml EX-101.DEF 151768
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20160331_lab.xml EX-101.LAB 496401
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20160331_pre.xml EX-101.PRE 263311
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 161619341
SIC: 2834 Pharmaceutical Preparations